School personnel information

写真b

FUJIKI Fumihiro


Keyword

WT1

URL

http://sahswww.med.osaka-u.ac.jp/~hmtonc/vaccine/

Organization 【 display / non-display

  • 2007.04.01 - 2009.07.31, Division of Health Sciences, Graduate School of Medicine, Specially Appointed Researcher

  • 2009.08.01 - 2010.09.30, Graduate School of Medicine, Assistant Professor

  • 2010.10.01 - 2017.11.30, Division of Health Sciences, Graduate School of Medicine, Assistant Professor

  • 2017.12.01 - , Division of Health Sciences, Graduate School of Medicine, Associate Professor

 

Academic Papers 【 display / non-display

  • Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments., Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H, Medicine,98(33) e16771, 2019.08, Papers

  • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma., Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H, Cancer immunology, immunotherapy : CII,68(2) 331-340, 2019.02, Other

  • A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma, Tsuboi A. , et al., Cancer Immunology, Immunotherapy,68(2) 331-340, 2019.02, Papers

  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides., Nakata J, Nakajima H, Hayashibara H, Imafuku K, Morimoto S, Fujiki F, Motooka D, Okuzaki D, Hasegawa K, Hosen N, Tsuboi A, Oka Y, Kumanogoh A, Oji Y, Sugiyama H, Oncotarget,9(89) 36029-36038, 2018.11, Papers

  • Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptide., Nakata J. et al, Oncotarget,9(89) 36029-36038, 2018.11, Papers

display all >>